GW Pharmaceuticals Plc (GWPH)

151.60
7.65 5.31
NASDAQ : Health Technology
Prev Close 143.95
Open 145.18
Day Low/High 145.18 / 152.48
52 Wk Low/High 90.14 / 179.65
Volume 492.81K
Avg Volume 445.30K
Exchange NASDAQ
Shares Outstanding 30.45M
Market Cap 4.38B
EPS -10.60
P/E Ratio N/A
Div & Yield N.A. (N.A)
How to Invest in Nasdaq-Traded Marijuana Stocks and Private Pot Companies

How to Invest in Nasdaq-Traded Marijuana Stocks and Private Pot Companies

Companies are seeking options for mainstream investors to get high gains. Americans can invest in multiple businesses traded publicly on the Nasdaq or take a private investment approach.

These 3 Marijuana-Related Stocks Are Poised for Strong Growth

These 3 Marijuana-Related Stocks Are Poised for Strong Growth

The medical marijuana business should rack up smoking gains. We've pinpointed the three stocks that will benefit the most.

'Mad Money' Lightning Round: Step Into Skechers Long Term

'Mad Money' Lightning Round: Step Into Skechers Long Term

Cramer says to wait on GW Pharmaceuticals but he likes Ashland's fundamentals.

Jim Cramer's 'Mad Money' Recap: We've Won the War Against the Dollar

Jim Cramer's 'Mad Money' Recap: We've Won the War Against the Dollar

Cramer says the Federal Reserve took a 'common sense' approach to interest rates by only taking action when needed.

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of GW Pharmaceuticals Plc Of Class Action And A Lead Plaintiff Deadline Of March 21, 2016

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of GW Pharmaceuticals Plc Of Class Action And A Lead Plaintiff Deadline Of March 21, 2016

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of GW Pharmaceuticals plc ("GW Pharmaceuticals") (NASDAQ: GWPH)...

Why Pot Stock GW Pharmaceuticals Could Go Even Higher in 2016

Why Pot Stock GW Pharmaceuticals Could Go Even Higher in 2016

As the marijuana industry becomes a multibillion-dollar business, shares of cannabinoid drug company GW Pharmaceuticals are getting quite high.

GWPH Momentum Passed Around to Other Pot Stocks

GWPH Momentum Passed Around to Other Pot Stocks

GW Pharmaceuticals saw its stock price surge amid news of a successful Epidiolex clinical trial. But that high also generated buzz across pot stocks at large.

GW Pharma (GWPH) Stock Spiked on Promising Cannabis-Derived Drug, Jim Cramer's Take

GW Pharma (GWPH) Stock Spiked on Promising Cannabis-Derived Drug, Jim Cramer's Take

GW Pharma (GWPH) stock more than doubled in Monday's trading session after its cannabis-derived drug demonstrated positive results.

Jim Cramer -- GW Pharma's Cannabinoid Treatment Could Be the Start

Jim Cramer -- GW Pharma's Cannabinoid Treatment Could Be the Start

GW Pharma's positive Phase 3 results for its Epidiolex drug could have far-reaching implications for other treatments, Cramer says.

Here's Why GW Pharma (GWPH) Stock Is Skyrocketing Today

Here's Why GW Pharma (GWPH) Stock Is Skyrocketing Today

GW Pharma (GWPH) stock has more than doubled in trading on Monday after its cannabis-based drug successfully treated children with severe epilepsy.

GW Pharma Marijuana Drug Cuts Seizure Rate in Pivotal Study

GW Pharma Marijuana Drug Cuts Seizure Rate in Pivotal Study

GW Pharma says it plans to discuss the positive findings from the phase III study with the U.S. Food and Drug Administration regarding a possible approval filing.

SHAREHOLDER ALERT: Law Office Of Brodsky & Smith, LLC Announces Investigation Of GW Pharmaceuticals Plc

SHAREHOLDER ALERT: Law Office Of Brodsky & Smith, LLC Announces Investigation Of GW Pharmaceuticals Plc

Law Office of Brodsky & Smith, LLC announces an investigation of GW Pharmaceuticals plc ("GW Pharmaceuticals" or the "Company") (Nasdaq: GWPH) for potential violations of federal securities laws and breaches of the GW...

SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notify Investors Of Class Action Lawsuit Involving GW Pharmaceuticals Plc And A Lead Plaintiff Deadline Of March 21, 2016

SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notify Investors Of Class Action Lawsuit Involving GW Pharmaceuticals Plc And A Lead Plaintiff Deadline Of March 21, 2016

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased GW Pharmaceuticals plc (Nasdaq: GWPH) securities...

'Mad Money' Lightning Round: Buy, Buy, Buy Bristol-Myers Squibb

'Mad Money' Lightning Round: Buy, Buy, Buy Bristol-Myers Squibb

Cramer still believes in Fitbit's long-term outlook but said Amicus Therapeutics is too speculative for him.

Jim Cramer's 'Mad Money' Recap: Commodities Are Healing, so Are Markets

Jim Cramer's 'Mad Money' Recap: Commodities Are Healing, so Are Markets

While many bears are dismissing the rally in commodity stocks as simple short covering, Cramer says there's actually a lot more in play.

Oversold Conditions For GW Pharmaceuticals (GWPH)

Oversold Conditions For GW Pharmaceuticals (GWPH)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of GW Pharmaceuticals Plc Of Class Action And A Lead Plaintiff Deadline Of March 21, 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of GW Pharmaceuticals Plc Of Class Action And A Lead Plaintiff Deadline Of March 21, 2016

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of GW Pharmaceuticals plc ("GW Pharmaceuticals") (NASDAQ: GWPH)...

IMPORTANT SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In GW Pharmaceuticals PLC To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

IMPORTANT SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In GW Pharmaceuticals PLC To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of...

INVESTOR ALERT: The Law Offices Of Vincent Wong Notify Investors Of Class Action Involving GW Pharmaceuticals Plc And A Lead Plaintiff Deadline Of March 21, 2016

INVESTOR ALERT: The Law Offices Of Vincent Wong Notify Investors Of Class Action Involving GW Pharmaceuticals Plc And A Lead Plaintiff Deadline Of March 21, 2016

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased GW Pharmaceuticals plc (Nasdaq:GWPH) securities...

Jim Cramer's 'Mad Money' Recap: This Week's Game Plan

Jim Cramer's 'Mad Money' Recap: This Week's Game Plan

With a slightly less brutal backdrop for the stock market, Cramer says earnings can once again command the spotlight for this week's trading.

'Mad Money' Lightning Round: Cramer Likes FedEx and UPS

'Mad Money' Lightning Round: Cramer Likes FedEx and UPS

Cramer likes FedEx in addition to Dollar General and Dollar Tree, and thinks Cypress Semiconductor is too cheap.

STOCK ALERT: Rosen Law Firm Reminds GW Pharmaceuticals Plc Investors Of Important Deadline In Class Action - GWPH

STOCK ALERT: Rosen Law Firm Reminds GW Pharmaceuticals Plc Investors Of Important Deadline In Class Action - GWPH

Rosen Law Firm, a global investor rights law firm, reminds purchasers of GW Pharmaceuticals plc securities (NASDAQ: GWPH) from December 4, 2014 through January 8, 2016, both dates inclusive (the "Class Period") of the...

Mood Swing Tape Continues

Market internals hit upside trend day levels just one day after hitting downside trend day levels.

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against GW Pharmaceuticals Plc - GWPH

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against GW Pharmaceuticals Plc - GWPH

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of GW Pharmaceuticals plc (NASDAQ:GWPH) securities from December 4, 2014 through January 8, 2016,...

TheStreet Quant Rating: D (Sell)